Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy

MT Newswires Live

06/23

Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.

The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.

The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.

Shares of the company were down 1.6% in early Tuesday trading.

Price: 2.57, Change: -0.04, Percent Change: -1.61

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2645834601"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2645834601\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2645834601?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645834601","market":"us","top_or_hot":-1,"title":"Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy","media":"MT Newswires Live","content":"<html><body><p> Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.</p><p>The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.</p><p>The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.</p><p>Shares of the company were down 1.6% in early Tuesday trading.</p><p>Price: 2.57, Change: -0.04, Percent Change: -1.61</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJaguar Health Files New Animal Drug Application For Full FDA Approval Of Canine Diarrhea Therapy\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-06-23 21:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.</p><p>The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.</p><p>The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.</p><p>Shares of the company were down 1.6% in early Tuesday trading.</p><p>Price: 2.57, Change: -0.04, Percent Change: -1.61</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LABU","symbol_name":"三倍做多標普生物-Direxion","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2645834601","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645834601","pubTimestamp":1782222885,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Jaguar Health  completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.Shares of the company were down 1.6% in early Tuesday trading.Price: 2.57, Change: -0.04, Percent Change: -1.61","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LABU":"三倍做多标普生物-Direxion","BK4007":"制药","JAGX":"Jaguar Animal Health, Inc.","BK4585":"ETF&股票定投概念","BK4588":"碎股"},"translate_title":"Jaguar Health提交新动物药物申请FDA全面批准犬类腹泻疗法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JAGX":1,"LABU":1.5},"content_text":"Jaguar Health (JAGX) completed the submission of its new animal drug application to the US Food and Drug Administration's Center for Veterinary Medicine, seeking full approval for crofelemer to treat chemotherapy-induced diarrhea in dogs, the company said Tuesday.The application incorporates findings from a clinical efficacy study in veterinary oncology centers alongside data involving subjects undergoing targeted tyrosine kinase inhibitor therapies, the company said.The medication operates as a non-antibiotic treatment mechanism and currently holds conditional agency approval for the canine indication, Jaguar Health said.Shares of the company were down 1.6% in early Tuesday trading.Price: 2.57, Change: -0.04, Percent Change: -1.61","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}